Centiva Capital’s Protalix BioTherapeutics PLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-130,332
Closed -$152K 1900
2024
Q2
$152K Buy
+130,332
New +$152K ﹤0.01% 1303